Elliot Cohen
Angel Investor
Boston, United States
Elliot Cohen is a seed investor in Boston focused on Health Care and Medical. Elliot Cohen is based out of Park City, Utah and is the Co-Founder and Chairman of the Board of General Medicine. Elliot previously worked at PillPack as a CPO and Co-Founder. Elliot Cohen attended Massachusetts Institute of Technology.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Elliot Cohen invests in
Stages Elliot Cohen invests in
Countries Elliot Cohen invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $1.8M–$11M
- Series A
- $9M–$20M
- Series B
- $20M–$50M
Investment Focus
Industry
- Health Care 10 (71%)
- Medical 3 (21%)
- Software 2 (14%)
- Wellness 2 (14%)
- Beauty 1 (7%)
Stage
- Seed 5 (36%)
- Series A 5 (36%)
- Series B 3 (21%)
- Pre-Seed 1 (7%)
Country
- United States 9 (64%)
- Brazil 1 (7%)
- Canada 1 (7%)
- United Kingdom 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Mevo is a healthcare platform that makes people's life simpler by providing everything from a digital prescription with an online purchase option for medicines to be delivered to their homes. Mevo is headquartered in São Paulo, Brazil and was founded in 2017. | $20.1M / Series B / Sep 18, 2024 | ||
| Medmo is a healthcare company that develops a platform to connect patients with local medical centers offering medical test and scanning services. Its platform connects patients with radiology centers offering a range of imaging tests such as MRI, CT scans, PET, and ultrasound. | $9M / Series A / Nov 20, 2023 | ||
| Commons Clinic is a multi-specialty clinic that provides healthcare treatment to patients. The company's clinic offers comprehensive specialty and surgical care programs for pain, orthopedics, women's health, and men's health, enabling patients to avail improved and efficient medical care.The company was founded in 2021 and isbased in Austin, Texas. | $19.5M / Series A / Oct 09, 2023 | ||
| Elaborate is a clinical intelligence platform that eliminates physician burnout by automating inbasket tasks. Using patient's own health data, it streamlines workflows for results management, referral processing, and visit preparation, freeing clinicians of time-consuming administrative work. Trusted by health systems, academic medicalcenters, and multi-specialty groups, Elaborate decreases administrative burden, enhances compliance, and improves patient communication. | $7.4M / Seed / Jan 26, 2023 | ||
| Caraway is a digital healthcare company for college women+ that provides integrated mental, reproductive and physical healthcare services. Built with students for students, Caraway arms women+ with the first personalized, equitable and digitally-accessible care solution that prioritizes their needs and concerns. With an unprecedented need formental health resources and new barriers and persistent inequities in women’s+ health, Caraway provides access to trusted, holistic, and compassionate healthcare so women+ can get the care they need when they need it. | $10.5M / Seed / Jul 26, 2022 | ||
| Ophelia offers medication and support for quitting opioids. They are a diverse collection of hearts and minds - doctors, scientists, techies, and citizens - on a mission to offer the best of medicine without the baggage of rehab. They are driven by science, committed to privacy, and bound to the client's right to make their own choices. Theybelieve in recommendations, not orders.It was founded in 2019 and is based in New York, New York. | $50M / Series B / Dec 14, 2021 | ||
| Personalized prenatal supplements and early screening rapid tests to improve access to care and accelerate time to care. Advocating for proactive family planning and reproductive health education. | $1.8M / Seed / Sep 16, 2021 | ||
| Centaur offers a platform and services for expert data annotation. We provide unmatched accuracy and scale by harnessing the collective intelligence of a global network of tens of thousands of students and professionals who compete with each other to be the best data annotator. | $15M / Series A / Aug 17, 2021 | ||
| Pet wellness, reimagined. | $10M / Series A / Jul 14, 2021 | ||
| Waeve is a VC-backed direct-to-consumer beauty startup that redefines the hair industry. It is a black woman-owned beauty startup offering beginner-friendly high-quality wigs. Waeve was founded in 2018 by co-founders Tiiso McGinty, Mary Imevbore, and Susana Hawken. | $2M / Seed / Jun 16, 2021 | ||
| See all 14 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Elliot Cohen invest in?
Elliot Cohen invests primarily in Health Care, Medical and Software startups, most often at Seed and Series A stage. Most of the 14 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Elliot Cohen invest in?
Elliot Cohen typically joins rounds of $1.8M–$11M at Seed, $9M–$20M at Series A and $20M–$50M at Series B. These are whole funding-round sizes, not Elliot Cohen's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Elliot Cohen took part in.
How do I contact Elliot Cohen?
Public channels for Elliot Cohen include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Elliot Cohen last invest?
The most recent investment recorded for Elliot Cohen closed in Sep 2024. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
